Wei Liang

1.9k total citations · 1 hit paper
47 papers, 1.3k citations indexed

About

Wei Liang is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Wei Liang has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Nephrology and 7 papers in Surgery. Recurrent topics in Wei Liang's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Dialysis and Renal Disease Management (5 papers). Wei Liang is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Dialysis and Renal Disease Management (5 papers). Wei Liang collaborates with scholars based in China, United States and Germany. Wei Liang's co-authors include Guohua Ding, Jijia Hu, Jun Feng, Zhaowei Chen, Zijing Zhu, Yiqiong Ma, Peng Zhang, Xu Zhang, Jingyan Chen and Yu Zhang and has published in prestigious journals such as Nature Communications, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

Wei Liang

44 papers receiving 1.3k citations

Hit Papers

Transition of acute kidne... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Liang China 22 738 322 199 147 142 47 1.3k
Feng Guo China 21 729 1.0× 260 0.8× 322 1.6× 112 0.8× 158 1.1× 67 1.4k
Xiaofen Xiong China 16 592 0.8× 285 0.9× 107 0.5× 123 0.8× 135 1.0× 22 1.2k
Rong Wang China 22 482 0.7× 441 1.4× 229 1.2× 120 0.8× 94 0.7× 71 1.3k
Chunling Huang China 21 565 0.8× 200 0.6× 92 0.5× 126 0.9× 132 0.9× 56 1.1k
Seon Ho Ahn South Korea 7 546 0.7× 446 1.4× 117 0.6× 177 1.2× 121 0.9× 11 1.2k
Chitose Suzuki Japan 17 534 0.7× 276 0.9× 91 0.5× 122 0.8× 114 0.8× 26 1.1k
Xiongzhong Ruan China 22 609 0.8× 217 0.7× 142 0.7× 237 1.6× 179 1.3× 45 1.3k
Shirong Zheng United States 20 649 0.9× 314 1.0× 73 0.4× 235 1.6× 129 0.9× 35 1.5k
Lucas Opazo-Ríos Spain 12 347 0.5× 291 0.9× 82 0.4× 111 0.8× 200 1.4× 20 1.0k
Juhong Yang China 17 406 0.6× 178 0.6× 140 0.7× 125 0.9× 238 1.7× 57 1.0k

Countries citing papers authored by Wei Liang

Since Specialization
Citations

This map shows the geographic impact of Wei Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Liang more than expected).

Fields of papers citing papers by Wei Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Liang. The network helps show where Wei Liang may publish in the future.

Co-authorship network of co-authors of Wei Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Liang. A scholar is included among the top collaborators of Wei Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Liang. Wei Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Zijing, Yun Cao, Qian Yang, et al.. (2025). CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease. Nature Communications. 16(1). 1528–1528. 10 indexed citations
2.
Chen, Xinghua, Zijing Zhu, Yiqun Hao, et al.. (2024). STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury. Cell Death and Disease. 15(3). 217–217. 42 indexed citations
3.
Fang, Qiwen, Fei Guo, Yong Yang, et al.. (2024). Molecular pathogen profiling of COVID-19 coinfections. BMC Infectious Diseases. 24(1). 1451–1451. 1 indexed citations
4.
Xiao, Fei, Yanling Wei, Congying Song, et al.. (2023). Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study. Clinical Kidney Journal. 16(11). 2059–2071. 6 indexed citations
5.
Hu, Jijia, et al.. (2023). LRH‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2‐mediated glutaminolysis. Cell Proliferation. 56(11). e13479–e13479. 8 indexed citations
6.
Chen, Zhaowei, Zijing Zhu, Wei Liang, et al.. (2023). Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement. Kidney International. 103(4). 735–748. 38 indexed citations
7.
Chen, Zhaowei, Zijing Zhu, Yiqun Hao, et al.. (2022). Angiotensin II induces podocyte metabolic reprogramming from glycolysis to glycerol-3-phosphate biosynthesis. Cellular Signalling. 99. 110443–110443. 6 indexed citations
8.
Chen, Zhaowei, Wei Liang, Jijia Hu, et al.. (2022). Sirt6 deficiency contributes to mitochondrial fission and oxidative damage in podocytes via ROCK1‐Drp1 signalling pathway. Cell Proliferation. 55(10). e13296–e13296. 21 indexed citations
9.
Zhu, Zijing, Jijia Hu, Zhaowei Chen, et al.. (2022). Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism. 131. 155194–155194. 108 indexed citations breakdown →
10.
Flisikowski, Krzysztof, Carolin Perleberg, Guanglin Niu, et al.. (2021). Wild-type APC Influences the Severity of Familial Adenomatous Polyposis. Cellular and Molecular Gastroenterology and Hepatology. 13(2). 669–671.e3. 3 indexed citations
11.
Ma, Yiqiong, Qian Yang, Jijia Hu, et al.. (2020). AKAP1 mediates high glucose‐induced mitochondrial fission through the phosphorylation of Drp1 in podocytes. Journal of Cellular Physiology. 235(10). 7433–7448. 53 indexed citations
12.
Yang, Qian, Jijia Hu, Yingjie Yang, et al.. (2020). Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes. Theranostics. 10(16). 7465–7479. 52 indexed citations
13.
Hu, Jijia, Qian Yang, Zhaowei Chen, et al.. (2019). Small GTPase Arf6 regulates diabetes‐induced cholesterol accumulation in podocytes. Journal of Cellular Physiology. 234(12). 23559–23570. 19 indexed citations
14.
Su, Ke, Ping Zeng, Wei Liang, et al.. (2017). FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines. Mediators of Inflammation. 2017. 1–14. 23 indexed citations
15.
Zhang, Yu, Wei Liang, Peng Zhang, et al.. (2017). Circular RNAs: emerging cancer biomarkers and targets. Journal of Experimental & Clinical Cancer Research. 36(1). 152–152. 164 indexed citations
16.
Schell, Christoph, Oliver Kretz, Wei Liang, et al.. (2015). The Rapamycin-Sensitive Complex of Mammalian Target of Rapamycin Is Essential to Maintain Male Fertility. American Journal Of Pathology. 186(2). 324–336. 19 indexed citations
17.
Zhang, Xiuli, Dan Liang, Lin Guo, et al.. (2012). Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1. Molecular Medicine Reports. 12(1). 1347–1355. 61 indexed citations
18.
Liang, Wei, et al.. (2009). Aldosterone Induces Apoptosis in Rat Podocytes: Role of PI3-K/Akt and p38MAPK Signaling Pathways. Nephron Experimental Nephrology. 113(1). e26–e34. 41 indexed citations
19.
Liang, Wei, et al.. (2008). Aldosterone induces mesangial cell apoptosis both in vivo and in vitro. American Journal of Physiology-Renal Physiology. 295(1). F73–F81. 42 indexed citations
20.
Mu, Qitian, Guifang Ouyang, Xiaopei Chen, et al.. (2008). [Inducing-apoptosis effect of bortezomib on acute monocytic leukemia cell SHI-1 and its influence on expressions of Bcl2l12, Bcl-2 and Bax genes].. PubMed. 16(5). 1016–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026